跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 286 条关于
“IMPEDE-FX RapidFill”
全部
286
临床试验
100
药物
45
机构
7
资讯
134
去年
First European Patient Enrolled in AAA-SHAPE Pivotal Trial Testing Novel Aneurysm Treatment
2个月前
Shape Memory Medical Raises $10 Million to Advance First Randomized Pivotal Trial of Aneurysm Sac Embolization After EVAR
去年
UK's NHS Data Access Barriers Impede Critical Medical Research, Sudlow Review Warns
去年
Flare Therapeutics Initiates Phase 1B Trial of First-in-Class PPARG Inhibitor FX-909 for Advanced Urothelial Cancer
6个月前
Flare Therapeutics Reports Promising Phase 1A Results for First-in-Class PPARG Inhibitor FX-909 in Advanced Urothelial Cancer
去年
Novo Nordisk Warns US Price Negotiations Will Impede Research as Three GLP-1 Drugs Face Scrutiny
去年
PD-1 Inhibitor Label Restrictions May Impede Gastric Cancer R&D
2个月前
Flare Therapeutics Secures $85M Series C, Appoints Anna Protopapas as CEO to Advance First-in-Class ARON Degrader for Prostate Cancer
去年
Ypsomed and CamDiab to Launch iOS Version of mylife Loop Automated Insulin Delivery System
去年
FDA Approves Medtronic's Evolut TAVR Systems for Expanded Redo-TAVR Indication
第 1 页,共 14 页
上一页
下一页